10x Genomics (TXG) Capital Expenditures Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 29.29 Bn | 27.22 Bn | 1.98 Bn | -43.42% |
| 2 | Veeva Systems | 26.21 Bn | 19.65 Bn | 622.47 Mn | 48.92% |
| 3 | BrightSpring Health Services | 11.98 Bn | 11.10 Bn | 482.22 Mn | -64.78% |
| 4 | Healthequity | 7.59 Bn | 7.27 Bn | 228.15 Mn | 4.91% |
| 5 | Hinge Health | 4.34 Bn | 4.03 Bn | 154.23 Mn | - |
| 6 | Waystar Holding | 3.75 Bn | 3.59 Bn | 268.04 Mn | 182.47% |
| 7 | Doximity | 3.73 Bn | 2.98 Bn | 125.97 Mn | 49.50% |
| 8 | 10x Genomics | 3.04 Bn | 2.50 Bn | 106.18 Mn | -93.77% |
| 9 | Privia Health | 2.83 Bn | 2.46 Bn | 595.71 Mn | - |
| 10 | Omnicell | 2.01 Bn | 1.84 Bn | 140.36 Mn | 1,174.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -93.77% |
| Dec 31, 2025 | -84.47% |
| Sep 30, 2025 | 114.21% |
| Jun 30, 2025 | -59.42% |
| Mar 31, 2025 | -0.32% |
| Dec 31, 2024 | 2,597.88% |
| Sep 30, 2024 | 82.11% |
| Jun 30, 2024 | 616.47% |
| Mar 31, 2024 | -93.81% |
| Dec 31, 2023 | -99.59% |
| Sep 30, 2023 | -3.64% |
| Jun 30, 2023 | -101.87% |
| Mar 31, 2023 | 104.14% |
| Dec 31, 2022 | 280.59% |
| Sep 30, 2022 | -139.41% |
| Jun 30, 2022 | 758.13% |
| Mar 31, 2022 | 433.49% |
| Dec 31, 2021 | -359.24% |
| Sep 30, 2021 | 12,894.89% |
| Jun 30, 2021 | -60.86% |
| Mar 31, 2021 | 0.18% |
| Dec 31, 2020 | -134.07% |
| Sep 30, 2020 | 116.07% |
| Jun 30, 2020 | 86.18% |
| Mar 31, 2020 | -12.97% |
| Dec 31, 2019 | 2,336.48% |